Zepp Health (NYSE:ZEPP – Get Free Report) and Mitesco (OTCMKTS:MITI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.
Insider & Institutional Ownership
52.6% of Zepp Health shares are held by institutional investors. Comparatively, 0.0% of Mitesco shares are held by institutional investors. 36.0% of Zepp Health shares are held by company insiders. Comparatively, 4.9% of Mitesco shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Zepp Health and Mitesco’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zepp Health | -28.28% | -21.45% | -9.20% |
| Mitesco | -7,638.20% | N/A | -2,270.77% |
Risk and Volatility
Analyst Ratings
This is a summary of recent ratings for Zepp Health and Mitesco, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zepp Health | 1 | 0 | 1 | 0 | 2.00 |
| Mitesco | 0 | 0 | 0 | 0 | 0.00 |
Zepp Health presently has a consensus price target of $64.37, indicating a potential upside of 124.47%. Given Zepp Health’s stronger consensus rating and higher probable upside, research analysts clearly believe Zepp Health is more favorable than Mitesco.
Valuation and Earnings
This table compares Zepp Health and Mitesco”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zepp Health | $182.60 million | 2.28 | -$75.73 million | ($4.11) | -6.98 |
| Mitesco | $40,000.00 | 47.72 | -$2.51 million | ($0.14) | -0.90 |
Mitesco has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.
Summary
Zepp Health beats Mitesco on 8 of the 14 factors compared between the two stocks.
About Zepp Health
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
About Mitesco
Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
